Does Dr. VLATKA AGNETTA have financial conflicts of interest?

Dr. VLATKA AGNETTA (M.D.) has received a total of $6,477 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $6,477 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. VLATKA AGNETTA?

According to CMS Open Payments data, Dr. VLATKA AGNETTA received funding from ABBVIE ($1,494), NOVARTIS PHARMACEUTICALS CORPORATION ($779), and SUN PHARMACEUTICAL INDUSTRIES ($674).

Does Dr. VLATKA AGNETTA receive research grants or speaking fees?

Dr. VLATKA AGNETTA has received $6,477 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. VLATKA AGNETTA

M.D.Real-Time Hydrated

Specialty: Dermatology, MOHS-Micrographic Surgery

Practice Location: CHATTANOOGA, TN 37421

NPI Number: 1053602128

LIFETIME INDUSTRY VALUE

$6,477

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. AGNETTA is a verified Dermatology, MOHS-Micrographic Surgery practitioner based in CHATTANOOGA, TN.

Between 2021 and 2024, Dr. AGNETTA had an overall industry promotional and research financial footprint of $6,477 as recorded in the federal CMS Open Payments database.

$6,477 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AGNETTA's primary funding source is ABBVIE, which accounts for $1,494 (representing 23.1% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ABBVIE

Rank 1

$1,494

23.1%

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 2

$779

12%

SUN PHARMACEUTICAL INDUSTRIES

Rank 3

$674

10.4%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.